Tech Company Financing Transactions
Bayhill Therapeutics Funding Round
Bayhill Therapeutics, operating out of Palo Alto, received $21.5 million from Montreux Equity Partners, Morgenthaler Ventures and U.S. Venture Partners.
Transaction Overview
Company Name
Announced On
12/31/2007
Transaction Type
Venture Equity
Amount
$21,505,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1804 Embarcadero Rd. 201
Palo Alto, CA 94303
USA
Palo Alto, CA 94303
USA
Phone
Website
Email Address
Overview
Bayhill Therapeutics Inc. is focused on the translation of research into therapeutics by developing novel drugs for the treatment of autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Hideki Garren
VP - Finance
Kwang Lee
VP - Manufacturing
Robert King
VP - Regulatory Affairs
Joanne Quan
Browse more venture capital transactions:
Prev: 12/31/2007: ZONARE Medical Systems venture capital transaction
Next: 12/31/2007: FitLinxx venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs